Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Higgins John L
Relationship:   Director
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   2,806,928    

Indirect Shares

   0      
Direct Value   $48,437,400    

Indirect Value

   $0      
Total Shares   2,806,928      
Total Value   $48,437,400      


Ligand Pharmaceuticals Inc $35,069,672 Techne Corp $2,827,968 OmniAb, Inc $10,539,760 Ligand Pharmaceuticals Inc $35,069,672 Techne Corp $2,827,968 OmniAb, Inc $10,539,760
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    11    

     Stock price went up :
    0   
    5    
     Stock price went down :
    0   
    6    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -34.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ligand Pharmaceuticals Inc LGND Director 2022-12-28 417,695 2007-02-01 0    Premium*  
            Techne Corp TECH Director 2024-05-14 36,608 2013-10-31 0    Premium*  
            OmniAb, Inc OABI Director 2024-01-30 2,352,625 2022-11-01 0    Premium*  
* Premium Members only  

Records found :    165         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-03-20 4 AS $109.10 $436,400 D/D (4,000) 139,171 0 -
TECH Techne Corp Director   –       •      –    2016-09-08 4 S $109.83 $186,716 D/D (1,700) 1,359 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2015-08-06 4 S $110.79 $516,946 D/D (4,666) 121,378 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-01-23 4 D $111.78 $756,192 D/D (6,765) 126,090 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-05-14 4 B $113.50 $283,750 D/D 2,500 143,899 2.81 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2022-01-26 4 D $113.68 $1,050,744 D/D (9,243) 349,018 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-03-13 4 B $114.29 $285,725 D/D 2,500 141,399 2.81 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-06-09 4 AS $114.87 $1,378,440 D/D (12,000) 139,171 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2016-09-22 4 S $117.34 $352,020 D/D (3,000) 122,664 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-06-21 4 AS $120.00 $559,920 D/D (4,666) 139,171 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2019-02-15 4 D $120.86 $594,269 D/D (4,917) 133,982 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2022-02-15 4 D $123.68 $732,557 D/D (5,923) 340,593 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-08-08 4 AS $125.00 $685,375 D/D (5,483) 139,171 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-09-05 4 AS $130.00 $650,000 D/D (5,000) 139,171 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-12-28 4 D $138.66 $720,893 D/D (5,199) 146,050 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-11-17 4 S $140.34 $316,888 D/D (2,258) 141,284 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-11-16 4 S $142.53 $750,991 D/D (5,269) 143,542 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2017-10-13 4 D $143.04 $249,462 D/D (1,744) 148,811 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2018-01-19 4 AS $151.92 $4,318,902 D/D (28,099) 134,200 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2021-01-25 4 D $156.01 $1,160,870 D/D (7,441) 243,422 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2018-02-15 4 AS $157.03 $1,413,279 D/D (9,000) 102,700 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2018-02-15 4 D $157.18 $981,118 D/D (6,242) 96,458 0 -
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2021-01-25 4 AS $159.00 $7,950,000 D/D (50,000) 235,310 0 %
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2021-11-12 4 S $160.50 $481,500 D/D (3,000) 335,095 0 %
LGND Ligand Pharmaceuticals In... Chief Executive Officer   •       •      –    2018-01-24 4 AS $165.00 $3,712,500 D/D (22,500) 111,700 0 -
  165  Records found
  1   2   3   4   5   6  7      
  Page 6 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us